25264333

Plosker S

2014

Effect of gastric bypass surgery on endocrine and metabolic abnormalities in polycystic ovary syndrome-preliminary findings and future challenges.

25266532

Ma H

2014

Value of qualitative research in polycystic ovary syndrome.

25267165

Tsai MJ

2014

Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.

25267785

Dewailly D

2014

Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.

25267790

Hendriks ML

2014

Short-term changes in hormonal profiles after laparoscopic ovarian laser evaporation compared with diagnostic laparoscopy for PCOS.

25268566

La Marca A

2015

The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study.

25268995

Ding CF

2015

Circulating microRNAs in patients with polycystic ovary syndrome.

25272362

de ?vila MA

2014

[Acanthosis nigricans: metabolic interrelations inherent to the polycystic ovary syndrome].

25280574

Abali R

2015

No relationship between osteoprotegerin concentrations and endothelial dysfunction in non-obese women with and without polycystic ovary syndrome.

25282112

Christiansen SC

2014

The effect of exercise and metformin treatment on circulating free DNA in pregnancy.

25282910

Feng Y

2014

[Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet].

25285307

Pan J

2013

Amygdala Kindling Alters Estrus Cycle and Ovarian Morphology in the Rat.

25286603

Udovika NO

2014

[Effectiveness of medical rehabilitation of women of reproductive age with fatigue syndrome].

25286823

Bhide P

2015

Serum anti-Mullerian hormone levels across different ethnic groups: a cross-sectional study.

25287137

Stefanaki C

2015

Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial.

25288096

Popova PV

2015

The new combination of risk factors determining a high risk of gestational diabetes mellitus.

25293340

Ho M

2014

Childhood obesity and insulin resistance: how should it be managed?

25294011

Moini A

2015

Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial.

25295506

Legro RS

2014

Letrozole or clomiphene for infertility in the polycystic ovary syndrome.

25295507

Bronson R

2014

Letrozole or clomiphene for infertility in the polycystic ovary syndrome.

25295508

Kruljac I

2014

Letrozole or clomiphene for infertility in the polycystic ovary syndrome.

25295622

Kort DH

2015

Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.

25297546

Szwarc MM

2014

The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction.

25300617

Arif M

2015

Disrupted hyaluronan binding protein 1 (HABP1) expression: one of the key mediator for ovarian dysfunction in polycystic ovary rat.

25300649

Asemi Z

2015

Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.

25301486

Wong M

2014

Semiquantitative assessment of hirsutism in 850 PCOS patients and 2,988 controls in China.

25301487

Kozakowski J

2014

Fetuin-A levels in lean and obese women with polycystic ovary syndrome.

25303485

Krishna MB

2015

Reduced Tregs in peripheral blood of PCOS patients - a consequence of aberrant Il2 signaling.

25303486

Zhao Y

2015

Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-?B signaling in the granulosa cells of PCOS patients.

25303487

Brower MA

2015

Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals.

25303490

Cook-Andersen H

2015

Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.

25304109

Luque-Ram?rez M

2014

Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.

25304269

Wang XH

2015

Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndrome.

25304843

Kurzthaler D

2014

Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects.

25310562

Lerchbaum E

2014

Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.

25310961

Lin MW

2014

Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population.

25311833

Chatterjee B

2014

Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.

25311971

Cui Y

2014

Mutational analysis of TOX3 in Chinese Han women with polycystic ovary syndrome.

25313914

Maas KH

2015

Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.

25317041

Akp?nar F

2014

Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome.

25318917

Sarapatkova H

2014

The importance of lipid spectrum changes in women with polycystic ovary syndrome(PCOS).

25319761

Leelaphiwat S

2015

Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.

25324541

Legro RS

2014

Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype.

25327320

Labarca G

2014

[Multisystemic involvement in obstructive sleep apnea].

25329139

Li J

2015

The relationship between serum anti-M?llerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.

25330463

Jensterle M

2015

Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.

25330687

Hagag P

2014

Role of the combination spironolactone-norgestimate-estrogen in Hirsute women with polycystic ovary syndrome.

25333030

Bertoldo MJ

2014

Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation.

25333031

Johnson NP

2014

Metformin use in women with polycystic ovary syndrome.

25335972

Kumar HP

2014

Classification of ovary abnormality using the probabilistic neural network (PNN).

25336070

Marsh CA

2014

Primary amenorrhea: diagnosis and management.

25336505

Zhang D

2015

Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation.

25336708

Liu DM

2014

Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.

25336711

Willis GR

2014

Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles.

25339479

Sahin S

2014

Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.

25339805

Kelley CE

2014

Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

25342852

Amato MC

2015

Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome.

25342854

Covington JD

2015

Potential effects of aerobic exercise on the expression of perilipin 3 in the adipose tissue of women with polycystic ovary syndrome: a pilot study.

25343339

Connolly F

2014

The local effects of ovarian diathermy in an ovine model of polycystic ovary syndrome.

25347896

Danilowicz K

2014

[Female hyperandrogenemia and normal serum levels of testosterone and sex hormone binding globulin].

25348326

Vagi SJ

2014

Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study.

25350347

Krysiak R

2015

The effect of atorvastatin and atorvastatin-ezetimibe combination therapy on androgen production in hyperandrogenic women with elevated cholesterol levels.

25351721

Khan GH

2015

Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration.

25355587

Walls ML

2015

In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes.

25356079

Davar R

2011

Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI.

25356655

Katulski K

2015

Pregnancy complications in polycystic ovary syndrome patients.

25359296

Yilmaz ?

2015

The effect of prolactin levels on MPV in women with PCOS.

25359859

Calderon-Margalit R

2014

Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study.

25364368

Nasri H

2014

Metformin: Current knowledge.

25366261

Moran LJ

2015

Vitamin D is independently associated with depression in overweight women with and without PCOS.

25366890

Javor S

2017

IRIS: methodological assessment of psychopathological disease in a cohort of hirsute women.

25369111

Agilli M

2015

Insulin sensitivity and leptin in women with PCOS.

25371056

G?d?c? N

2014

Retinol-binding protein 4, as a negative acute-phase reactant in polycystic ovary syndrome.

25372737

Palioura E

2014

Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects.

25373012

De Leo V

2014

[Combination inositol and glucomannan in PCOS patients].

25373013

Ademoglu E

2014

Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome.

25373529

Souza Dos Santos AC

2015

The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.

25374239

Zhao PL

2014

Functional investigation on aromatase in endometrial hyperplasia in polycystic ovary syndrome cases.

25374394

Cordeiro FB

2015

Follicular fluid lipid fingerprinting from women with PCOS and hyper response during IVF treatment.

25374607

Benk Silfeler D

2014

Does polycystic ovary syndrome itself have additional effect on apelin levels?

25375303

Dahan MH

2014

Collection of 125 oocytes in an in vitro maturation cycle using a new oocyte collection technique: a case report.

25377599

Basios G

2015

The impact of metformin treatment on adiponectin and resistin levels in women with polycystic ovary syndrome: a prospective clinical study.

25379154

Attlee A

2014

Polycystic ovary syndrome in university students: occurrence and associated factors.

25379156

Bazarganipour F

2014

Sexual Functioning among Married Iranian Women with Polycystic Ovary Syndrome.

25381947

Senaldi L

2015

Is ultrasound useful in the diagnosis of adolescents with polycystic ovary syndrome?

25381981

De Simone C

2014

A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis.

25385669

Beltsos AN

2014

Patients' administration preferences: progesterone vaginal insert (Endometrin?) compared to intramuscular progesterone for Luteal phase support.

25387259

M?nzker J

2015

Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.

25393639

Ambekar AS

2015

Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development.

25393642

Tosi F

2015

Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome.

25398203

Carreau AM

2015

PCOS in adolescence and type 2 diabetes.

25398743

LeMieux MJ

2014

Nutrimetabolomics.

25402193

Kabil Kucur S

2015

How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?

25402369

Polyzos SA

2014

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.

25402379

Savic-Radojevic A

2015

Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome.

25402380

Macut D

2015

The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.

25403280

Kohln? Papp I

2014

[Psychosocial approach in polycystic ovary syndrome].

25403326

Oztekin O

2015

Serum HLA-G levels in women with polycystic ovary syndrome.

25406011

Tso LO

2014

Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.

25408702

Moazami Goudarzi Z

2014

Laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome: A systematic review and meta-analysis.